The results, in fact, will be analyzed by independent experts and the US Food and Drug Administration.
The results will, in fact, be analyzed by independent experts and the US Food and Drug Administration. The pharmaceutical giant and its partner BioNTech have published interim results last week of the last tests that confirmed the effectiveness of the vaccine to 90%. The data released today is based on the first 170 cases of the virus in clinical trials. The vaccine has been tested in 43,500 people in six countries and no safety concerns have been raised.
The study will continue to collect safety and efficacy data on volunteers for another two years.
